Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to 0.5.

  • Organogenesis Holdings' Equity Ratio fell 1982.12% to 0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5, marking a year-over-year decrease of 1982.12%. This contributed to the annual value of 0.53 for FY2024, which is 1283.18% down from last year.
  • Organogenesis Holdings' Equity Ratio amounted to 0.5 in Q3 2025, which was down 1982.12% from 0.51 recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Equity Ratio high stood at 0.62 for Q3 2024, and its period low was 0.49 during Q1 2021.
  • Its 5-year average for Equity Ratio is 0.56, with a median of 0.56 in 2022.
  • Per our database at Business Quant, Organogenesis Holdings' Equity Ratio soared by 20472.05% in 2021 and then tumbled by 1982.12% in 2025.
  • Organogenesis Holdings' Equity Ratio (Quarter) stood at 0.54 in 2021, then grew by 8.59% to 0.59 in 2022, then rose by 2.46% to 0.61 in 2023, then fell by 12.83% to 0.53 in 2024, then dropped by 5.23% to 0.5 in 2025.
  • Its last three reported values are 0.5 in Q3 2025, 0.51 for Q2 2025, and 0.52 during Q1 2025.